S2 E19. "Now I’ve joined pharma does that mean I will have to stop."
A new pharma employee asked us about using LinkedIn - hear our advice or access our checklist.
20 Kesä 20243min
S2 E18. Guess what - disease awareness should be about a disease!
Rina discusses a recent complaint vs GSK - it did not breach the Code but WHY? Jean asks all the questions a good signatory should be considering based on our checklist. See Code Clarity's LinkedIn pa...
13 Kesä 20244min
S2 E17. How to become a Signatory
Sophie Hodge from Medaptive shares her experience and recommendations on becoming a Signatory (spoiler alert - there's not a shortcut!)
6 Kesä 20246min
S2 E16. Claims, claims, claims...
Why are there still so many breaches about claims?! Rina & Jean discuss why these may appear and why pushing the boundaries is important.
30 Touko 20243min
S2 15. When is a 'consultant' not a 'consultant'?
LinkedIn does not allow promotion via InMail - a recent case (https://bit.ly/44y9YyB) vs Tetris tells us about targeting and the importance of social media platform policies.
23 Touko 20243min
S2 14. Are the PMCPA acting like shouty (ignored) parents?
Trends from Q1 published PMCPA rulings show a staggering 96% allege poor standards - what does this mean and what can we do about this?
16 Touko 20243min
S2 E13 Bad v Good Signatories
Sarah Hollywood from HollywoodMedico chats to Jean about ' bad blocker' signatories and provides tips on how 'good' signatories can give teams the competitive edge.
9 Touko 20245min
S2 E12 Want to know how to make a complaint to the PMCPA?
Rubbish complaints cause confusing PMCPA rulings which lead to pharma's lack of clarity. Here are 5 top tips to lodge the "perfect" complaint to the PMCPA.
2 Touko 20245min
